Celldex Therapeutics (CLDX) Update / Briefing Transcript

Celldex Therapeutics (CLDX) Update / Briefing August 19, 2025 04:30 PM ET Speaker0Please be advised that today's conference is being recorded.I'd now like to hand the conference over to Sarah Kavanaugh. Please go ahead.Speaker1Thank you. Good afternoon, and thank you for joining us to discuss the top line results from our Phase II bardezolizumab program in eosinophilic esophagitis, or EOE. Joining me on the call today are Anthony Marucci, Co Founder, President and CEO Doctor. Tibor Keller, Co Founder, EVP a ...